A discussion about the future of biotech would be incomplete without addressing the potential of artificial intelligence and machine learning (ML) to completely change the sector.
A discussion about the future of biotech would be incomplete without addressing the potential of artificial intelligence and machine learning (ML) to completely change the sector. Companies founded on accelerating drug development with this technology are maturing to the clinical stage. Large pharmaceutical companies are increasingly interested in enhancing their own R&D capabilities via internal investments and partnerships with AI firms.